Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
biotech
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
novartis
cancer
clinical trials
crispr
eli lilly
fda
startups
biogen
deals
gene therapy
gilead sciences
glaxosmithkline
ipo
What
bio
10
×
new
10
×
roundup
drug
ipo
medicines
cancer
companies
crispr
develop
isn’t
later
medical
million
news
pharmaceutical
raised
remains
science
time
years
accelerating
activity
advantages
aims
alleviate
allogene
analysis
announced
approval
approvals
area
arm
bails
bar
bets
billion
biogen
biogen’s
biopharma
Language
unset
Current search:
new
×
bio
×
@techcrunch.com
2 months ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@thenextweb.com
7 years ago
Chan Zuckerberg initiative pledges $3B to wipe out disease